Author

Paul Sutej

Institution: Northside Hospital

Observed institution: Northside Hospital

OpenAlex ID: A5000738919

Sustained Pericarditis Recurrence Risk Reduction With Long‐Term Rilonacept

2024 · Massimo Imazio, Allan L. Klein, et al. · Journal of the American Heart Association · 48

Pericardial late gadolinium enhancement and time to recurrence: a substudy from RHAPSODY, a phase 3 clinical trial of rilonacept in recurrent pericarditis

2023 · Paul C Cremer, David Lin, et al. · European Heart Journal - Imaging Methods and Practice · 27

Absence of Pericarditis Recurrence in Rilonacept-Treated Patients With COVID-19 and SARS-CoV-2 Vaccination: Results From the RHAPSODY Long-term Extension

2024 · Antonio Brucato, Lucia Trotta, et al. · CJC Open · 6

Abstract 11653: Prolonged Rilonacept Treatment in Rhapsody Long-Term Extension Provided Persistent Reduction of Pericarditis Recurrence Risk

2022 · Massimo Imazio, Allan L Klein, et al. · Circulation · 5

Prolonged Rilonacept Treatment in RHAPSODY Long-Term Extension Provided Persistent Reduction of Pericarditis Recurrence Risk

2023 · Corina Grancorvitz, Massimo Imazio, et al. · 2

Works count: 5

Citation count: 88

H-index: 4

I10-index: 2